Matthew Harty is the Director of Quality Operations for Biologics at BIOVECTRA, where he leads quality assurance and testing at a GMP facility. An expert in bioanalytical method development with a Masters from Dalhousie University, he has progressed through several scientific roles within the company, specializing in proteomics, HPLC, and mass spectrometry.
Outside of his scientific career, Matthew has a background as an Infantry Soldier with the Canadian Armed Forces. This experience highlights a unique and diverse personal history beyond his corporate and research roles.
Unique fact: Matthew transitioned from serving as an Infantry Soldier in the Canadian Armed Forces to a leadership role in biologic pharmaceutical manufacturing.
Read the full overview →While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They are more likely than others to negotiate on pricing and terms. They prefer to fully evaluate every situation.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.